Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cerebellar Ataxia

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Cerebellar Ataxia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dichgans, J; Jauch, M; Klockgether, T; Müller-Schauenburg, W; Petersen, D; Schulz, JB; Spieker, S; Voigt, K1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cerebellar Ataxia

ArticleYear
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:9

    Topics: Adult; Aged; Benzamides; Brain; Cerebellar Ataxia; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine; Tomography, Emission-Computed, Single-Photon

1994